Sukoon Takaful PJSC (DFM:SUKOONTAKAFL)

CTI BioPharma Ratios and Metrics

Market cap in millions AED. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	216	239	245	285	276	293
Market Cap Growth	-26.88%	-2.52%	-14.05%	3.35%	-5.79%	2.70%
Enterprise Value	70	233	112	188	126	121
PE Ratio	9.45	12.57	-	-	42.82	9.96
PS Ratio	1.82	2.56	2.74	1.99	2.73	2.61
PB Ratio	1.06	1.23	1.40	1.13	0.89	0.92
P/FCF Ratio	5.04	-	-	-	-	-
P/OCF Ratio	4.95	-	-	-	-	-
EV/Sales Ratio	0.59	2.50	1.25	1.31	1.25	1.08
EV/EBITDA Ratio	2.62	10.95	-	-	18.62	4.08
EV/EBIT Ratio	2.72	11.18	-	-	19.62	4.14
EV/FCF Ratio	1.64	-	-	-	-	-
Debt / Equity Ratio	-	-	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	-	-	-	-	0.19	0.02
Quick Ratio	0.85	0.91	1.54	1.13	0.96	1.35
Current Ratio	1.21	1.29	1.76	1.38	1.54	1.97
Asset Turnover	0.26	0.23	0.21	0.30	0.21	0.23
Return on Equity (ROE)	11.87%	10.26%	-35.87%	-10.93%	2.05%	9.66%
Return on Assets (ROA)	3.54%	3.25%	-11.47%	-4.29%	0.82%	3.71%
Return on Capital (ROIC)	8.35%	7.03%	-22.34%	-7.23%	1.28%	6.02%
Earnings Yield	10.59%	7.95%	-31.25%	-10.77%	2.33%	10.04%
Earnings Yield	10.59%	7.95%	-31.25%	-10.77%	2.33%	10.04%
FCF Yield	19.83%	-3.02%	-20.22%	-3.32%	-1.48%	-6.59%
Dividend Yield	-	-	-	-	9.12%	6.09%
Payout Ratio	-	-	-	-	239.20%	-
Total Shareholder Return	-	-	-	-	9.12%	6.09%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.